• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-(哌啶基)-5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-甲酰胺(SR141716)的构象受限类似物:设计、合成、计算分析及生物学评价

Conformationally constrained analogues of N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716): design, synthesis, computational analysis, and biological evaluations.

作者信息

Zhang Yanan, Burgess Jason P, Brackeen Marcus, Gilliam Anne, Mascarella S Wayne, Page Kevin, Seltzman Herbert H, Thomas Brian F

机构信息

Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, NC 27709, USA.

出版信息

J Med Chem. 2008 Jun 26;51(12):3526-39. doi: 10.1021/jm8000778.

DOI:10.1021/jm8000778
PMID:18512901
Abstract

Structure-activity relationships (SARs) of 1 (SR141716) have been extensively documented, however, the conformational properties of this class have received less attention. In an attempt to better understand ligand conformations optimal for receptor recognition, we have designed and synthesized a number of derivatives of 1, including a four-carbon-bridged molecule (11), to constrain rotation of the diaryl rings. Computational analysis of 11 indicates approximately 20 kcal/mol energy barrier for rotation of the two aryl rings. NMR studies have determined the energy barrier to be approximately 18 kcal/mol and suggested atropisomers could exist. Receptor binding and functional studies with these compounds displayed reduced affinity and potency when compared to 1. This indicates that our structural modifications either constrain the ring systems in a suboptimal orientation for receptor interaction or the introduction of steric bulk leads to disfavored steric interactions with the receptor, and/or the relatively modest alterations in the molecular electrostatic potentials results in disfavored Coulombic interactions.

摘要

1(SR141716)的构效关系(SARs)已有大量文献记载,然而,这类化合物的构象性质却较少受到关注。为了更好地理解最适合受体识别的配体构象,我们设计并合成了多种1的衍生物,包括一种四碳桥连分子(11),以限制二芳基环的旋转。对11的计算分析表明,两个芳基环旋转的能量屏障约为20千卡/摩尔。核磁共振研究确定能量屏障约为18千卡/摩尔,并表明可能存在阻转异构体。与1相比,这些化合物的受体结合和功能研究显示亲和力和效力降低。这表明我们的结构修饰要么将环系统限制在与受体相互作用的次优方向,要么引入的空间体积导致与受体不利的空间相互作用,和/或分子静电势的相对适度变化导致不利的库仑相互作用。

相似文献

1
Conformationally constrained analogues of N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716): design, synthesis, computational analysis, and biological evaluations.N-(哌啶基)-5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-甲酰胺(SR141716)的构象受限类似物:设计、合成、计算分析及生物学评价
J Med Chem. 2008 Jun 26;51(12):3526-39. doi: 10.1021/jm8000778.
2
Synthesis and structure-activity relationships of amide and hydrazide analogues of the cannabinoid CB(1) receptor antagonist N-(piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716).
J Med Chem. 2002 Jun 20;45(13):2708-19. doi: 10.1021/jm010498v.
3
Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.三环吡唑。3. 大麻素拮抗剂8-氯-1-(2',4'-二氯苯基)-N-哌啶-1-基-1,4,5,6-四氢苯并[6,7]环庚并[1,2-c]吡唑-3-甲酰胺类似物的合成、生物学评价及分子模拟
J Med Chem. 2005 Nov 17;48(23):7351-62. doi: 10.1021/jm050317f.
4
Methoxy- and fluorine-substituted analogs of O-1302: synthesis and in vitro binding affinity for the CB1 cannabinoid receptor.O-1302的甲氧基和氟取代类似物:合成及其对CB1大麻素受体的体外结合亲和力
Chem Pharm Bull (Tokyo). 2007 Aug;55(8):1213-7. doi: 10.1248/cpb.55.1213.
5
Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activities.大麻素CB1受体拮抗剂N-(哌啶基)-5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-甲酰胺(SR141716)具有独特结合选择性和药理活性的长链酰胺类似物的合成。
Bioorg Med Chem. 2005 Sep 15;13(18):5463-74. doi: 10.1016/j.bmc.2005.06.005.
6
Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.拮抗剂N-(哌啶-1-基)-5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-甲酰胺与CB1大麻素受体的分子相互作用
J Med Chem. 2002 Mar 28;45(7):1447-59. doi: 10.1021/jm010267o.
7
Synthesis, biological evaluation, and structural studies on N1 and C5 substituted cycloalkyl analogues of the pyrazole class of CB1 and CB2 ligands.吡唑类CB1和CB2配体的N1和C5取代环烷基类似物的合成、生物学评价及结构研究
Bioorg Med Chem. 2004 Jan 15;12(2):393-404. doi: 10.1016/j.bmc.2003.10.045.
8
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2',4'-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide.三环吡唑。4. 强效选择性CB2大麻素配体1-(2',4'-二氯苯基)-6-甲基-N-哌啶-1-基-1,4-二氢茚并[1,2-c]吡唑-3-甲酰胺类似物的合成与生物学评价
J Med Chem. 2006 Dec 14;49(25):7502-12. doi: 10.1021/jm060920d.
9
Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interaction.大麻素CB1受体的联芳基吡唑反向激动剂:C-3羧酰胺氧/赖氨酸3.28(192)相互作用的重要性
J Med Chem. 2006 Oct 5;49(20):5969-87. doi: 10.1021/jm060446b.
10
Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor.NESS 0327的合成与表征:一种新型的假定CB1大麻素受体拮抗剂
J Pharmacol Exp Ther. 2003 Jul;306(1):363-70. doi: 10.1124/jpet.103.049924. Epub 2003 Mar 27.

引用本文的文献

1
Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB/CB Receptor Interaction.三环吡唑类化合物作为大麻素 CB/CB 受体相互作用的有用支架。
Molecules. 2021 Apr 7;26(8):2126. doi: 10.3390/molecules26082126.
2
In silico investigation of interactions between human cannabinoid receptor-1 and its antagonists.计算机模拟研究人类大麻素受体-1 与其拮抗剂的相互作用。
J Mol Model. 2012 Aug;18(8):3831-45. doi: 10.1007/s00894-012-1381-8. Epub 2012 Mar 9.
3
Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity.
朝向大麻素受体 1(CB1)拮抗剂外周选择性的合理设计。
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5711-4. doi: 10.1016/j.bmcl.2011.08.032. Epub 2011 Aug 11.
4
Endocannabinoid tone versus constitutive activity of cannabinoid receptors.内源性大麻素基调与大麻素受体的组成活性。
Br J Pharmacol. 2011 Aug;163(7):1329-43. doi: 10.1111/j.1476-5381.2011.01364.x.
5
Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor.合成和生物评价大麻素 1 受体的双价配体。
J Med Chem. 2010 Oct 14;53(19):7048-60. doi: 10.1021/jm1006676.